Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 1, 2002, Pages 68-74

  Dempsey, Owen J ^a   Kennedy, Gwen ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenosine monophosphate; Asthma; Corticosteroid; Inflammation; Leukotriene antagonist; Methacholine; Montelukast; Triamcinolone acetonide

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL ADHESION MOLECULE; CORTICOSTEROID; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; FLUORINATED HYDROCARBON; HYDROCORTISONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; MONTELUKAST; NITRIC OXIDE; OSTEOCALCIN; PLACEBO; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DRUG DOSE; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0036154901     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.120559     Document Type: Article

References (24)

1. The British guidelines on asthma management: 1995 Review and position statement
2. Airway mucosal inflammation even in patients with newly diagnosed asthma
3. Airway inflammation in mild intermittent and in persistent asthma
4. A 15-year follow-up study of ventilatory function in adults with asthma
5. Airways remodeling is a distinctive feature of asthma and is related to severity of disease
6. Leukotriene-receptor antagonists
7. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
8. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
9. Montelukast added to inhaled beclomethasone in treatment of asthma
10. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial
11. Standardization of spirometry: 1994 Update
12. Measurement of airway responsiveness to methacholine: Relative importance of the precision of drug delivery and the method of assesing response
13. Guidelines for methacholine and exercise challenge testing
14. Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients
15. Exhaled and nasal nitric oxide measurements: Recommendations
16. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids
17. Bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
18. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
19. Effects of 2 weeks treatment with fluticasone 100mg bd by comparison with zafirlukast 20mg bd on bronchial hyperresponsiveness in mild to moderate asthma
20. Montelukast, a once daily leukotriene receptor antagonist in the treatment of chronic asthma: A multicentre, randomized double-blind trial
21. Relationship between activated eosinophils of the bronchial mucosa and serum eosinophil cationic protein in atopic asthma
22. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations
23. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast